Pharmafile Logo
Pharmafocus logo
Advanced Search
phrma_logo

US Pharma launches multi-million dollar media campaign to deflect pricing criticism

January 24, 2017
Manufacturing and Production, Medical Communications PhMRA, Trump

In response to a number of recent criticisms over pricing including president Trump’s message that pharma companies are “getting away …

News
roche_close

Roche’s Actemra granted Priority Review by FDA

January 24, 2017
Manufacturing and Production, Sales and Marketing Actemra, FDA, Roche, priority review

Roche’s drug, Actemra (also known as RoActemra in Europe), has been granted priority review designation by the FDA for the …

News
computer_doctor

Thinking big data

January 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, IBM Watson Health, ibm

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …

Feature
kaleo

Rival to EpiPen to be made available to many for free

January 23, 2017
Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival

Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …

News
vaccination-1215279_960_720

CEPI backed by Bill Gates raises funds to combat epidemics

January 23, 2017
Medical Communications, Sales and Marketing Bill & Melinda Gates foundation, Bill Gates, CEPI

CEPI, the Coalition for Epidemic Preparedness Innovations, have launched the beginning of its fundraising initiative – with the aim of …

News
treasure_map

Leaflets offering gold coins for paediatricians appear at Bengaluru event

January 23, 2017
Medical Communications, Sales and Marketing India, PEDICON

Pharmaceutical firms in India are not allowed to offer any kind of reimbursement for privileging certain treatment over others, this …

News

Artificial skin development has implications for clinical trials

January 23, 2017
Medical Communications, Sales and Marketing Seoul National University Hospital, artificial skin, dermatology

Researchers from Seoul National University Hospital have announced that it has developed a microchip that has been designed to replicate …

News

BMS receives $625 million patent settlement boost from Merck

January 23, 2017
Sales and Marketing BMS, MSD, Merck, keytruda, opdivo

Bristol-Myers Squibb were in desperate need of releasing good news after the brief announcement that it would no longer be …

News
mallinckrodt-project

Company in 85,000% infant epilepsy drug price increase receives $100 million fine

January 23, 2017
Sales and Marketing Mallinckrodt, Martin Skhreli

Mallinckrodt Pharmaceuticals has hit the headlines for particularly dispiriting reasons – with further evidence of practise by some companies that …

News
shutterstock_141105490

Asia-Pacific flu market to hit $1.71bn by 2022

January 20, 2017
Business Services, Medical Communications APAC, GBI Research

According to new data from intelligence provider GBI Research, the flu vaccines market in the Asia-Pacific (APAC) region is set …

News
biopsy

“Biggest leap in decades” for prostate cancer, 1 in 4 could avoid biopsies

January 20, 2017
Medical Communications, Research and Development Biposy, prostate cancer

A new study has estimated that one in four men could avoid unnecessary invasive biopsies to detect prostate cancer – …

News

J&J’s Imbruvica scores fifth FDA lymphoma approval

January 20, 2017
Medical Communications, Research and Development, Sales and Marketing FDA, Marginal Zone Lymphoma, imbruvica

Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 20, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …

News
jenny_tragner_-_main

Pharmaceutical R&D tax credit regulatory legislation: The need for clarity

January 20, 2017
Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …

News

Sanofi diabetes drug Sulinqua green-lighted in Europe

January 19, 2017
Research and Development, Sales and Marketing Sanofi, Sulinqua

Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …

News
bi_german_building_at_night

Boehringer steps into Humira race with US and EU biosimilar filings

January 19, 2017
Sales and Marketing Boehringer Ingelheim, Humira, biosimilar

Boehringer Ingelheim has just stepped into the ring to battle it out for a slice of Humira’s revenue with accepted …

News
abbas-hussain

GSK snatches AZ Europe VP to replace exiting global head of pharma

January 19, 2017
Business Services, Medical Communications, Sales and Marketing Abbas Hussain, Luke Miels

GlaxoSmithKline has announced that its global head of pharmaceuticals Abbas Hussain (pictured) is leaving the company; the vacated role will …

News
allergan

Allergan fined £15m over failure to disclose merger discussions

January 19, 2017
Sales and Marketing Allergan, SEC

Allergan has been fined $15 million by the Security and Exchange Commission (SEC) after committing disclosure violations during merger talks …

News
headquarters_2_web

Lilly brings migraine drug home with $960m acquisition

January 19, 2017
Sales and Marketing CoLucid Pharmaceuticals, Eli Lilly

Eli Lilly has announced it is to shell out $960 million to snatch up CoLucid Pharmaceuticals and specifically its migraine …

News
shutterstock_159488225

Alcobra axes ADHD drug after Phase 3 failure

January 18, 2017
Research and Development ADHD, Alcobra, metadoxine

Israeli-based firm Alcobra is to pull the plug on its experimental attention deficit hyperactivity disorder (ADHD) drug metadoxine after it …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026